By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.
Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...
WASHTENAW COUNTY, MI - January has begun, and you may thinking 2025 is finally your year. As a way to reset after holiday ...